Selective apoptotic cell death effects of oral cancer cells treated with destruxin B

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Huang Liu, Rosa ^a   Chen, Shih Pin ^a,b   Lu, Tsong Ming ^a,b   Tsai, Wei Yu ^a   Tsai, Chung Hung ^a,b   Yang, Chi Chiang ^a,b   Tzeng, Yew Min ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; Cytotoxicity; Destruxin; Oral cancer

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE 3; DESTRUXIN; DESTRUXIN B; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; GINGIVA TUMOR; GINGIVAL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUTH SQUAMOUS CELL CARCINOMA; NECK METASTASIS; NONHUMAN; ORAL CANCER CELL LINE; TONGUE CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GINGIVA; HEAD AND NECK NEOPLASMS; HUMANS; INHIBITORY CONCENTRATION 50; MOUTH NEOPLASMS;

EID: 84902901951     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-207     Document Type: Article

References (39)

1. Dong C, Zhang J, Huang H, Chen W, Hu Y. Pathogenicity of a new China variety of Metarhizium anisopliae (M. Anisopliae var. Dcjhyium) to subterranean termite Odontotermes formosanus. Microbiol Res 2009, 164(1):27-35.
2. Cavelier F, Verducci J, Andre F, Haraux F, Sigalat C, Traris M, Vey A. Natural cyclopeptides as leads for novel pesticides: tentoxin and destruxins. Pestic Sci 1998, 52(1):81-89.
3. Quiot JM, Vey A, Vago C. Effects of mycotoxins on invertebrate cells in vitro. Adv Cell Cult 1985, 4:199-212.
4. Sun CM, Chen HC, Yeh SF. Suppressive effects of metabolites from Alternaria brassicaea on the hepatitis B surface antigen. Planta Med 1994, 60(1):87-88.
5. Yeh SF, Pan W, Ong GT, Chiou AJ, Chuang CC, Chiou SH, Wu SH. Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells. Biochem Biophys Res Commun 1996, 4;229(1):65-72.
6. Chen HC, Chou CK, Sun CM, Yeh SF. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res 1997, 34(3):137-144.
7. Morel E, Pais M, Turpin M, Guyot M. Cytotoxicity of cyclodepsipeptides on murine lymphocytes and on L 1210 leukemia cells. Biomed Pharmacother 1983, 37(4):184-185.
8. Odier F, Vago P, Quiot JM, Devauchelle G, Bureau JP. Cytometric study of the effects of destruxin E on leukemic cells in mice. CR Acad Sci III 1987, 305(14):575-578.
9. Odier F, Vey A, Bureau JP. In vitro effect fungal cyclodepsipeptides on leukemic cells: study of destruxins A, B and E. Biol Cell 1992, 74:267-271.
10. Lee YP, Wang CW, Liao WC, Yang CR, Yeh CT, Tsai CH, Yang CC, Tzeng YM. In vitro and in vivo xenograft mice inhibitory effects of Destruxin B on human colorectal cancer. Anticancer Res 2012, 32(7):2735-2745.
11. Dornetshuber-Fleiss R, Heffeter P, Mohr T, Hazemi P, Kryeziu K, Seger C, Berger W, Lemmens-Gruber R. Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities. Biochem Pharmacol 2013, 1;86(3):361-377.
12. Chao PZ, Chin YP, Hsu IU, Liu CM, Yu YC, Leung TK, Lee YJ, Chen CH, Lin YF. Apoptotic toxicity of destruxin B in human non-Hodgkin lymphoma cells. Toxicol In Vitro 2013, 27:1870-1876.
13. Wu CC, Chen TH, Liu BL, Wu LC, Chen YC, Tzeng YM, Hsu SL. Destruxin B isolated from entomopathogenic fungus Metarhizium anisopliae induces apoptosis via a Bcl-2 family-dependent mitochondrial pathway in human nonsmall cell lung cancer cells. Evid Based Complement Alternat Med 2013, 2013:548929.
14. Ye AY, Hay JH, Laskin JJ, Wu JS, Ho CC. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab. J Cancer Res Ther 2013, 9(4):607-612.
15. Sankaranarayanan R, Black RJ, Parkin DM. Cancer Survival in Developing Countries. 1998, Lyon, France: International Agency for Research on Cancer, IARC Scientific Publication No. 145.
16. Lee YJ, Liao PH, Chen WK, Yang CC. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett 2000, 153:51-56.
17. Tsai WC, Rao YK, Lin SS, Chou MY, Shen YT, Wu CH, Geethangili M, Yang CC, Tzeng YM. Methylantcinate A induces tumor specific growth inhibition in oral cancer cells via Bax-mediated mitochondrial apoptotic pathway. Bioorg Med Chem Lett 2010, 20:6145-6148.
18. Lee YP, Tsai WC, Ko CJ, Rao YK, Yang CR, Chen DR, Yang MH, Yang CC, Tzeng YM. Anticancer effects study of eleven triterpenoids derived from Antrodia camphorata. Anticancer Res 2012, 32(7):2727-2734.
19. Liu BL, Rou TM, Rao YK, Tzeng YM. Effect of pH and aeration rate on the production of destruxins A and B from Metarhizium anisopliae. Int J Appl Sci Eng 2007, 5(1):17-26.
20. Chen JW, Liu BL, Tzeng YM. Purification and quantification of destruxins A and B from Metarhizium anisopliae. J Chromatogr A 1999, 830(1):115-125.
21. Huang CR, Lin SS, Chou MY, Ho CC, Wang L, Lee YL, Chen CS, Yang CC. Demonstrating different mode of cell death upon HSV-1 infection in different oral cell populations. Acta Virol 2005, 49:7-15.
22. Huang TH, Yang CC, Ding SJ, Yen M, Chou MY, Kao CT. Biocompatibility of human osteosarcoma cells to root end filling materials. J Biomed Mater Res 2005, 72B(1):140-145.
23. Xu FL, Lee YL, Tsai WY, Lin SJ, Yang ZQ, Yang CC, Liu HY, Cheng L, Xiao H, Wen L. Effect of cordycepin on hantaan virus 76-118 infection of primary human embryonic pulmonary fibroblasts- characterization of apoptotic effects. Acta Virol 2005, 49:183-193.
24. Cheng MH, Cheng HT, Lin SS, Young SC, Pai CJ, Liao PH, Chen SC, Chou MY, Yang JJ, Yang CC. Apoptotic characteristics of MMC-treated HeLa cells and cellular localization and characteristics of induced P-glycoprotein 170. Drug Chem Toxicol 2009, 32:158-168.
25. Lin HW, Hsieh YS, Yang YY, Hu CC, Chiou SC, Yang CC. A novel modified silver staining for detecting protein, DNA and RNA in polyacrylamide gels. J Biomed Lab Sci 1999, 11(4):122-127.
26. Yang CC, Lin SJ, Lin KL. A newly identified true late protein of HSV-1 possibly encoded by UL49.5. J Biomed Lab Sci 1999, 11(4):111-117.
27. Yang CC, Yang YY, Lin KL, Lin SJ. The different forms of HSV-1 VP22a within purified virion and infected cells. J Microbiol Immunol Infect 2000, 33:63-68.
28. Pradelli LA, Beneteau M, Ricci JE. Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 2010, 67:1589-1597.
29. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 87:99-163.
30. Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Disc 2008, 7:1001-1012.
31. Silverman S. Demographics and occurrence of oral and oropharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001, 132(1):7S-11S.
32. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005, 55(2):74-108.
33. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80(6):827-841.
34. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009, 45(4-5):309-316.
35. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinomas: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999, 35(2):173-179.
36. Reichart PA, Nguyen XH. Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med 2008, 37(9):511-514.
37. Zhang X, Li C, Liao Q, Reichart PA. Areca chewing in Xiangtan, Hunan province, China: interviews with chewers. J Oral Pathol Med 2008, 37(7):423-429.
38. Diaz EM, Holsinger C, Zuniga ER, Roberts DB, Sorensen D. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck 2003, 25(4):267-273.
39. Richardson A, Kaye SB. Pharmacological inhibition of the bcl-2 family of apoptosis regulators as cancer therapy. Curr Mol Pharmacol 2008, 1:244-254.